Scientific Industries, Inc. (SCND)
OTCMKTS
· Delayed Price · Currency is USD
0.750
-0.096 (-11.34%)
At close: Apr 27, 2026
Scientific Industries Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | 2021 - 2017 |
| Revenue | 5.05 | 4.8 | 11.11 | 10.88 | 11.4 | Upgrade
|
| Revenue Growth (YoY) | 5.35% | -56.83% | 2.13% | -4.57% | 16.63% | Upgrade
|
| Cost of Revenue | 3.75 | 2.79 | 6.01 | 5.75 | 5.66 | Upgrade
|
| Gross Profit | 1.3 | 2.01 | 5.1 | 5.13 | 5.74 | Upgrade
|
| Selling, General & Admin | 6.41 | 7.33 | 10.8 | 10.36 | 10.13 | Upgrade
|
| Research & Development | 2.49 | 2.9 | 3.57 | 2.75 | 2.87 | Upgrade
|
| Operating Expenses | 8.9 | 10.22 | 14.36 | 13.11 | 13 | Upgrade
|
| Operating Income | -7.6 | -8.22 | -9.26 | -7.98 | -7.26 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.18 | 0.11 | 0.03 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.69 | -0.01 | 0.01 | -0.06 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -6.77 | -8.04 | -9.14 | -8.01 | -7.17 | Upgrade
|
| Impairment of Goodwill | - | - | - | -4.28 | -4.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.02 | 0.02 | 0.05 | -0.16 | -0.27 | Upgrade
|
| Asset Writedown | -0.29 | - | - | -0.05 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.43 | Upgrade
|
| Pretax Income | -7.04 | -8.02 | -9.09 | -12.5 | -11.28 | Upgrade
|
| Income Tax Expense | 0 | - | - | 3.13 | 2.39 | Upgrade
|
| Earnings From Continuing Operations | -7.04 | -8.02 | -9.09 | -15.63 | -13.67 | Upgrade
|
| Earnings From Discontinued Operations | 5.82 | 1.58 | 0 | -0.01 | 0 | Upgrade
|
| Net Income | -1.22 | -6.45 | -9.09 | -15.64 | -13.67 | Upgrade
|
| Net Income to Common | -1.22 | -6.45 | -9.09 | -15.64 | -13.67 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 10 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 10 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 8.01% | 3.53% | 46.79% | 4.12% | 108.10% | Upgrade
|
| EPS (Basic) | -0.11 | -0.61 | -0.90 | -2.26 | -2.06 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.61 | -1.27 | -2.26 | -2.06 | Upgrade
|
| Free Cash Flow | -5.52 | -3.78 | -6.29 | -6.96 | -5.95 | Upgrade
|
| Free Cash Flow Per Share | -0.49 | -0.36 | -0.62 | -1.01 | -0.90 | Upgrade
|
| Gross Margin | 25.79% | 41.83% | 45.92% | 47.17% | 50.32% | Upgrade
|
| Operating Margin | -150.35% | -171.28% | -83.34% | -73.35% | -63.72% | Upgrade
|
| Profit Margin | -24.15% | -134.36% | -81.78% | -143.77% | -119.89% | Upgrade
|
| Free Cash Flow Margin | -109.19% | -78.85% | -56.58% | -63.93% | -52.17% | Upgrade
|
| EBITDA | -6.99 | -7.47 | -8.51 | -7.24 | -6.58 | Upgrade
|
| EBITDA Margin | -138.28% | -155.63% | -76.55% | -66.53% | -57.68% | Upgrade
|
| D&A For EBITDA | 0.61 | 0.75 | 0.75 | 0.74 | 0.69 | Upgrade
|
| EBIT | -7.6 | -8.22 | -9.26 | -7.98 | -7.26 | Upgrade
|
| EBIT Margin | -150.35% | -171.28% | -83.34% | -73.35% | -63.72% | Upgrade
|
| Advertising Expenses | 0.28 | 0.32 | 0.47 | - | 0.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.